Abstract

S INCE 1963, we have been conducting a s tudy of var ious osmotherapeut ie agents, TM including hypertonic mannitol n and hyper tonic fructose. As a result of these studies, we have developed a new osmotherapeut ic agent, composed of 30% fructose and 15% manni to l in water. We have found this material , which we call Fruc ton-M,* the ideal agent for reducing increased intracranial pressure. This paper summarizes the studies which led to the deve lopment of F r u c t o n M and the clinical results wc have obtained using it.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.